Market overview
The global robotic catheterization systems market is worth USD 944 mn in 2026 and is forecast to reach USD 3.8 bn by 2036, growing at a 15.0% CAGR. United States is the largest country market and Disposable catheters and instruments is the largest by component segment.
| Scope | Robot-assisted catheter platforms, consoles and single-use catheters for lung biopsy, cardiac electrophysiology and endovascular procedures, sold to hospitals. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 800 mn |
| Value 2026 | USD 944 mn |
| Value 2036 | USD 3.8 bn |
| CAGR 2026-2036 | 15.0% |
| Volume 2026 | 333,737 procedures |
| Volume 2036 | 1,492,902 procedures |
| Average price 2026 | USD 2,829 per procedure |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Robotic Catheterization Systems market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 944 mn |
| 2027 | USD 1.1 bn |
| 2028 | USD 1.2 bn |
| 2029 | USD 1.4 bn |
| 2030 | USD 1.7 bn |
| 2031 | USD 1.9 bn |
| 2032 | USD 2.2 bn |
| 2033 | USD 2.5 bn |
| 2034 | USD 2.9 bn |
| 2035 | USD 3.3 bn |
| 2036 | USD 3.8 bn |
Robotic Catheterization Systems market segmentation
By component
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Robotic systems | 30.0% | 21.6% | USD 283 mn | 11.3% |
| Disposable catheters and instruments | 54.0% | 65.8% | USD 510 mn | 17.3% |
| Service and software | 16.0% | 12.6% | USD 151 mn | 12.3% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Lung biopsy and bronchoscopy | 62.0% | 66.2% | USD 585 mn | 15.8% |
| Cardiac electrophysiology | 22.0% | 15.1% | USD 208 mn | 10.8% |
| Endovascular and other | 16.0% | 18.6% | USD 151 mn | 16.8% |
By robot type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Magnetic navigation | 38.0% | 34.0% | USD 359 mn | 13.7% |
| Mechanical remote | 42.0% | 42.0% | USD 396 mn | 15.0% |
| Image-guided autonomous | 20.0% | 24.0% | USD 189 mn | 17.1% |
By procedure
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Cardiac EP and ablation | 36.0% | 34.0% | USD 340 mn | 14.3% |
| Coronary and PCI | 24.0% | 26.0% | USD 227 mn | 15.9% |
| Peripheral and neurovascular | 20.0% | 22.0% | USD 189 mn | 16.1% |
| Bronchial and urological | 20.0% | 18.0% | USD 189 mn | 13.8% |
By setting
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospital cath labs | 76.0% | 72.0% | USD 717 mn | 14.4% |
| Ambulatory cardiac centres | 16.0% | 18.0% | USD 151 mn | 16.4% |
| Teaching and research sites | 8.0% | 10.0% | USD 76 mn | 17.6% |
Top 25 countries for robotic catheterization systems by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 95.0% of 2026 revenue and the 25 countries below together hold 98.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 623 mn | 66.0% | USD 2.5 bn | 14.9% |
| 2 | China | USD 47 mn | 5.0% | USD 290 mn | 19.9% |
| 3 | Japan | USD 38 mn | 4.0% | USD 137 mn | 13.8% |
| 4 | Germany | USD 38 mn | 4.0% | USD 126 mn | 12.8% |
| 5 | United Kingdom | USD 28 mn | 3.0% | USD 103 mn | 13.8% |
| 6 | France | USD 28 mn | 3.0% | USD 95 mn | 12.9% |
| 7 | Italy | USD 28 mn | 3.0% | USD 95 mn | 12.9% |
| 8 | South Korea | USD 28 mn | 3.0% | USD 145 mn | 17.8% |
| 9 | Canada | USD 19 mn | 2.0% | USD 69 mn | 13.8% |
| 10 | Spain | USD 19 mn | 2.0% | USD 65 mn | 13.2% |
| 11 | India | USD 7.2 mn | 0.8% | USD 35 mn | 17.1% |
| 12 | Netherlands | USD 4.2 mn | 0.5% | USD 15 mn | 13.1% |
| 13 | Switzerland | USD 3.1 mn | 0.3% | USD 11 mn | 13.1% |
| 14 | Australia | USD 2.5 mn | 0.3% | USD 8.8 mn | 13.2% |
| 15 | Taiwan | USD 2.2 mn | 0.2% | USD 7.3 mn | 12.8% |
| 16 | Israel | USD 1.9 mn | 0.2% | USD 9.2 mn | 17.1% |
| 17 | Belgium | USD 1.7 mn | 0.2% | USD 5.7 mn | 12.9% |
| 18 | Poland | USD 1.5 mn | 0.2% | USD 7.3 mn | 17.0% |
| 19 | Turkey | USD 1.4 mn | 0.1% | USD 6.9 mn | 17.1% |
| 20 | Mexico | USD 1.2 mn | 0.1% | USD 6.1 mn | 17.4% |
| 21 | Sweden | USD 1.2 mn | 0.1% | USD 4.2 mn | 13.1% |
| 22 | Brazil | USD 1.1 mn | 0.1% | USD 5.3 mn | 16.8% |
| 23 | Austria | USD 1.0 mn | 0.1% | USD 3.4 mn | 12.7% |
| 24 | Singapore | USD 0.94 mn | 0.1% | USD 5.0 mn | 18.1% |
| 25 | Saudi Arabia | USD 0.94 mn | 0.1% | USD 4.6 mn | 17.1% |
| Rest of world | USD 15 mn | 1.6% | USD 61 mn | 15.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Intuitive
- Johnson & Johnson MedTech
Group 2: Regional and specialist players
- Stereotaxis
- Robocath
- Noah Medical
Group 3: Emerging and niche players
- Microbot Medical
- Nanoflex Robotics
- XCath
- Catheter Precision
- Remedy Robotics
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the robotic catheterization systems market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 15.0% is calculated from the resulting values.
The market is divided by component, by application, by robot type, by procedure, by setting. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the robotic catheterization systems market?
The global robotic catheterization systems market is estimated at USD 800 mn in 2025 and USD 944 mn in 2026.
How fast will the robotic catheterization systems market grow?
It is forecast to reach USD 3.8 bn by 2036, a compound annual growth rate of 15.0% from 2026, an increase of USD 2.9 bn.
Which country is the largest market for robotic catheterization systems?
United States is the largest market by revenue at USD 623 mn in 2026, 66.0% of the global total. The three largest countries together hold 75.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 19.9% a year from 2026 to 2036.
Which robotic catheterization systems segment is largest?
In the by component split, Disposable catheters and instruments is the largest segment with 54.0% of 2026 revenue.
Who are the leading robotic catheterization systems companies?
Global leaders include Intuitive, Johnson & Johnson MedTech.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Glioblastoma Treatment DrugsUSD 945 mn · 5.5% CAGR
- Epilepsy Monitoring DevicesUSD 942 mn · 7.5% CAGR
- Virus InactivationUSD 935 mn · 10.0% CAGR
- Early Pulmonary Embolism Thrombectomy DeviceUSD 935 mn · 12.0% CAGR
- Radiotherapy Positioning DevicesUSD 933 mn · 5.8% CAGR
- Biosafety CabinetUSD 958 mn · 7.0% CAGR
- Digital Twins TechnologiesUSD 967 mn · 21.0% CAGR
- Endoluminal & Bronchoscopy RobotsUSD 976 mn · 17.0% CAGR